Rapid Response to Mycophenolate Mofetil in Combination with Romiplostim in a Case of Severe Refractory Immune Thrombocytopenia Post COVID-19 Vaccination

Abstract

Vaccine mediated immune mediated thrombocytopenia (ITP) is exceedingly rare. We present a case of a young female who developed severe refractory ITP with multiple bleeding sites post second dose of COVID-19 vaccination. She was treated with a combination of romiplostim and mycophenolate mofetil that resulted in rapid platelet count recovery

    Similar works